Physical Activity Levels of Breast Cancer Patients Before Diagnosis Compared to a Reference Population: A Cross-Sectional Comparative Study.


Journal

Clinical breast cancer
ISSN: 1938-0666
Titre abrégé: Clin Breast Cancer
Pays: United States
ID NLM: 100898731

Informations de publication

Date de publication:
07 2022
Historique:
received: 02 03 2020
revised: 29 11 2021
accepted: 11 12 2021
pubmed: 12 1 2022
medline: 23 6 2022
entrez: 11 1 2022
Statut: ppublish

Résumé

We hypothesize that prediagnosis physical activity (PA) levels of breast cancer patients are below those of a reference population without breast cancer. Therefore, the aim of the present study was to compare prediagnosis PA levels (including total-, occupational-, sport- and household activity levels) of breast cancer patients with activity levels of a reference population. Female patients with primary breast cancer (n = 265) filled in the Flemish Physical Activity Computerized Questionnaire (FPACQ) the day before surgery recalling the year before diagnosis. PA levels were expressed as Metabolic Equivalent Task (MET) values. Smooth reference curves of PA levels were estimated in a representative sample of 3466 women without breast cancer with the LMS method, which allowed comparison of prediagnosis PA data of the breast cancer sample with this reference. Compared to women without breast cancer, total PA levels were significantly lower in the year prior to breast cancer diagnosis over all age groups (Mean ± SD z-scores (95% CI) = -1.51 ± 1.86 (-1.74 to -1.29)). More specifically, household PA levels of breast cancer patients were significantly lower between ages 40-60, while occupational PA levels were significantly higher in this age group. No differences were found between sports PA levels. Patients with breast cancer show significantly lower total PA levels during the year prior to surgery compared to a reference population. Especially household activity levels are lower in patients between ages 40 and 60. Given this, a return to prediagnosis PA levels may not be sufficient for protection from disease in the future.

Identifiants

pubmed: 35012888
pii: S1526-8209(21)00357-8
doi: 10.1016/j.clbc.2021.12.006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e708-e717

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Disclosure All authors declare that they have no conflict of interest.

Auteurs

An De Groef (A)

Department of Rehabilitation Sciences, KU Leuven - University of Leuven, Leuven, Belgium; Department of Rehabilitation Sciences and Physiotherapy, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. Electronic address: an.degroef@kuleuven.be.

Heleen Demeyer (H)

Department of Rehabilitation Sciences, KU Leuven - University of Leuven, Leuven, Belgium; Department of Rehabilitation Sciences, Ghent University, Ghent, Belgium; Department of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.

Carlijn de Kinkelder (C)

Vrije Universiteit Brussel - Department of Physiotherapy, Physiology & Anatomy, Faculty of Physical Education and Physiotherapy, Brussels, Belgium; Belgium and European College for Lymphology & Oncology, Jette, Belgium.

Sanne Dukers-van Althuis (S)

Vrije Universiteit Brussel - Department of Physiotherapy, Physiology & Anatomy, Faculty of Physical Education and Physiotherapy, Brussels, Belgium; Belgium and European College for Lymphology & Oncology, Jette, Belgium.

Anne Asnong (A)

Department of Rehabilitation Sciences, KU Leuven - University of Leuven, Leuven, Belgium.

Lore Dams (L)

Department of Rehabilitation Sciences and Physiotherapy, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

Elien Van der Gucht (E)

Department of Rehabilitation Sciences, KU Leuven - University of Leuven, Leuven, Belgium.

Tessa De Vrieze (T)

Department of Rehabilitation Sciences, KU Leuven - University of Leuven, Leuven, Belgium.

Vincent Haenen (V)

Department of Rehabilitation Sciences, KU Leuven - University of Leuven, Leuven, Belgium.

Margaux Evenepoel (M)

Department of Rehabilitation Sciences, KU Leuven - University of Leuven, Leuven, Belgium.

Inge Geraerts (I)

Department of Rehabilitation Sciences, KU Leuven - University of Leuven, Leuven, Belgium.

Mathieu Roelants (M)

Environment and Health, Department of Public Health and Primary Care, KU Leuven - University of Leuven, Leuven, Belgium.

Jannique van Uffelen (J)

Department of Movement Sciences, KU Leuven - University of Leuven, Leuven, Belgium.

Thierry Troosters (T)

Department of Rehabilitation Sciences, KU Leuven - University of Leuven, Leuven, Belgium; Department of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.

Nele Devoogdt (N)

Department of Rehabilitation Sciences, KU Leuven - University of Leuven, Leuven, Belgium; Department of Vascular Surgery, University Hospitals Leuven, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH